Effects of Oral L-Citrulline Supplementation on Lipoprotein Oxidation and Endothelial Dysfunction in Humans with Vasospastic Angina.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 26005507)

Published in Immunol Endocr Metab Agents Med Chem on September 01, 2013

Authors

Masahiko Morita1, Masami Sakurada2, Fumiko Watanabe1, Tetsuo Yamasaki2, Hiroshi Doi2, Hirotaka Ezaki2, Koji Morishita1, Takayuki Miyakex2

Author Affiliations

1: Function Research Group, Healthcare Products Development Center, KYOWA HAKKO BIO CO., LTD., 2, Miyukigao-ka, Tsukuba, Ibaraki 305-0841, Japan.
2: Tokorozawa Heart Center, 2-61-11, Kamiarai, Tokorozawa, Saitama 359-1142, Japan.

Articles cited by this

Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation (2001) 5.87

An endothelial receptor for oxidized low-density lipoprotein. Nature (1997) 3.76

Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circ Res (2007) 2.96

Amino acids and immune function. Br J Nutr (2007) 2.48

L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. JAMA (2006) 2.24

Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation (1998) 2.08

Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation (1996) 2.06

Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community. Circulation (2009) 2.05

Almost all about citrulline in mammals. Amino Acids (2005) 1.90

Nitric oxide, cell bioenergetics and neurodegeneration. J Neurochem (2006) 1.90

Coronary risk factors, endothelial function, and atherosclerosis: a review. Clin Cardiol (1997) 1.86

LOX index, a novel predictive biochemical marker for coronary heart disease and stroke. Clin Chem (2010) 1.65

Randomized trial of a medical food for the dietary management of chronic, stable angina. J Am Coll Cardiol (2002) 1.55

Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism. Br J Clin Pharmacol (2007) 1.53

Association of small dense LDL with coronary artery disease and diabetes in urban Asian Indians - the Chennai Urban Rural Epidemiology Study (CURES-8). J Assoc Physicians India (2005) 1.50

Regulation of enzymes of urea and arginine synthesis. Annu Rev Nutr (1992) 1.49

Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System. Clin Chem (2001) 1.49

Dietary L-arginine supplementation reduces fat mass in Zucker diabetic fatty rats. J Nutr (2005) 1.44

Flow-mediated vasodilation and the risk of developing hypertension in healthy postmenopausal women. J Am Coll Cardiol (2004) 1.39

Citrulline, a novel compatible solute in drought-tolerant wild watermelon leaves, is an efficient hydroxyl radical scavenger. FEBS Lett (2001) 1.32

Lectin-like oxidized LDL receptor-1 is a cell-adhesion molecule involved in endotoxin-induced inflammation. Proc Natl Acad Sci U S A (2003) 1.29

Therapeutic use of citrulline in cardiovascular disease. Cardiovasc Drug Rev (2007) 1.27

Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients. Kidney Int (2002) 1.20

Oral L-arginine improves endothelial function in healthy individuals older than 70 years. Vasc Med (2003) 1.19

l-Citrulline and l-arginine supplementation retards the progression of high-cholesterol-diet-induced atherosclerosis in rabbits. Proc Natl Acad Sci U S A (2005) 1.19

Role of neutral amino acid transport and protein breakdown for substrate supply of nitric oxide synthase in human endothelial cells. Circ Res (2003) 1.15

Heart disease in Asia. Circulation (2008) 1.12

Endothelial dysfunction in heart failure. Pharmacol Rep (2008) 1.09

Dietary supplementation with watermelon pomace juice enhances arginine availability and ameliorates the metabolic syndrome in Zucker diabetic fatty rats. J Nutr (2007) 1.05

Chronic treatment with nitric oxide-releasing aspirin reduces plasma low-density lipoprotein oxidation and oxidative stress, arterial oxidation-specific epitopes, and atherogenesis in hypercholesterolemic mice. Proc Natl Acad Sci U S A (2002) 1.04

Dose-ranging effects of citrulline administration on plasma amino acids and hormonal patterns in healthy subjects: the Citrudose pharmacokinetic study. Br J Nutr (2007) 1.03

The role of small, dense low density lipoprotein (LDL): a new look. Int J Cardiol (2000) 1.02

Short-term effects of L-citrulline supplementation on arterial stiffness in middle-aged men. Int J Cardiol (2010) 0.97

Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study. Eur Heart J (2012) 0.91

Nitric oxide in blood. The nitrosative-oxidative disequilibrium hypothesis on the pathogenesis of cardiovascular disease. FEBS J (2007) 0.89

Intracellular L-arginine concentration does not determine NO production in endothelial cells: implications on the "L-arginine paradox". Biochem Biophys Res Commun (2011) 0.88

Endothelial dysfunction is an independent factor responsible for vasospastic angina. Clin Sci (Lond) (2001) 0.87

The effect of L-citrulline ingestion on ECG QT interval and autonomic nervous system activity. J Physiol Anthropol (2011) 0.83

Short-term treatment with L-arginine prevents the smoking-induced impairment of endothelial function and vascular elastic properties in young individuals. Int J Cardiol (2007) 0.83

Prolonged L-arginine on cardiovascular mass and myocardial hemodynamics and collagen in aged spontaneously hypertensive rats and normal rats. Hypertension (1999) 0.82

Coronary vasospasm in ischemic heart disease. Chest (1980) 0.82

Supplements of L-arginine attenuate the effects of high-fat meal on endothelial function and oxidative stress. Int J Cardiol (2007) 0.81

Watermelon extract supplementation reduces ankle blood pressure and carotid augmentation index in obese adults with prehypertension or hypertension. Am J Hypertens (2012) 0.81